Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD - authors' reply

被引：0
|
作者：
Ben-Horin, S. [1 ,2 ,3 ,4 ]
Chowers, Y. [1 ,2 ,3 ,4 ]
机构：
[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Gastroenterol, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Sch Med, Haifa, Israel
[4] Technion Israel Inst Technol, Rambam Hlth Care Campus, Haifa, Israel
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2012年 / 36卷 / 05期
关键词：
D O I：
10.1111/j.1365-2036.2012.05215.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：501 / 501
页数：1
相关论文
共 50 条
  • [21] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Miha Kosmač
    Tadej Avčin
    Nataša Toplak
    Gabriele Simonini
    Rolando Cimaz
    Vladka Čurin Šerbec
    Pediatric Research, 2011, 69 : 243 - 248
  • [22] ANTI-INFLIXIMAB ANTIBODIES IMPAIR CLINICAL RESPONSE TO INFLIXIMAB IN JIA ASSOCIATED UVEITIS
    Metha, R.
    Tay-Kearney, M.
    Manners, P.
    Murray, K.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 32 - 33
  • [23] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [24] Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies
    van Schie, Karin A.
    Heer, Pleuni Ooijevaar-De
    Kruithof, Simone
    Plasencia, Chamaida
    Jurado, Teresa
    Salcedo, Dora Pascual
    Brandse, Johannan F.
    d'Haens, Geert R. A. M.
    Wolbink, Gerrit Jan
    Rispens, Theo
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1285 - 1288
  • [25] Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
    Casteele, N. Vande
    Buurman, D. J.
    Sturkenboom, M. G. G.
    Kleibeuker, J. H.
    Vermeire, S.
    Rispens, T.
    van der Kleij, D.
    Gils, A.
    Dijkstra, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 765 - 771
  • [26] New Assay to Detect Infliximab Levels and Anti-Infliximab Antibodies From a Single Serum Sample is Useful in Measuring Efficacy of Treatment With Infliximab in Children With IBD
    Veres, Gabor
    Kaplan, Jess L.
    De Greef, Elisabeth
    Chuang, Emil
    Szabo, Doloresz
    Molnar, Kriszta
    Ohrmund, Linda
    Hauenstein, Scott
    Singh, Sharat
    Arato, Andras
    Veereman, Gigi
    Winter, Harland S.
    GASTROENTEROLOGY, 2012, 142 (05) : S386 - S386
  • [27] Therapeutic drug monitoring of infliximab biosimilar and anti-infliximab antibodies in inflammatory diseases
    Elberdin, Laida
    Outeda, Maria
    Mateos, Maria
    Martinez, Cristina
    Salvador, Pilar
    Angeles Porta, Maria
    Isabel Martin, Maria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 338 - 339
  • [28] FOUR-WAY COMPARISON OF ELISA METHODS AVAILABLE FOR THE MEASUREMENT OF INFLIXIMAB AND ANTI-INFLIXIMAB ANTIBODY IN IBD PATIENTS
    Unsworth, N.
    Samaan, M. A.
    Warner, B.
    Arkir, Z.
    Irving, P. M.
    GUT, 2016, 65 : A84 - A84
  • [29] Can Measurements of Anti-Infliximab Antibodies Predict Acute Severe Infusion Reactions to Infliximab?
    Steenholdt, Casper
    Svenson, Morten
    Bendtzen, Klaus
    Thomsen, Ole
    Brynskov, Jorn
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2011, 140 (05) : S774 - S774
  • [30] Anti-infliximab antibodies developed in patients treated for severe hidradenitis suppurativa
    Peeters, M. -A.
    Laffitte, E.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 12 - 12
12345